Skip to content, Open navigation or Skip to contact information.

Copyright © Inderes 2011 - present. All rights reserved.
Latest
Markets
Stock Comparison
Calendar
Research
Articles
inderesTV
Portfolio
Forum
Customer Companies
Settings
Copyright © Inderes 2011 - present. All rights reserved.
​

Latest content

Showing All content types
Analyst Comment

Recap on InDex Pharmaceuticals and update on PK results with Cobitolimod.

2023-03-29 by Claus Thestrup
InDex Pharmaceuticals Holding
Analyst Comment

Zerion Pharma: A disruptive solution for poor drug solubility

2023-03-16 by Claus Thestrup
Zerion Pharma
Analyst Comment

NeoDynamics: Management elaborates on options for long-term financing

2023-03-16 by Claus Thestrup
Neodynamics
Analyst Comment

Introduktion til nyt dansk biotekselskab Pharma Equity Group

2023-03-06 by Claus Thestrup
Pharma Equity Group
Analyst Comment

Qlife - Soft-launch of their first CRP biomarker test under the Egoo Health brand

2023-03-04 by Claus Thestrup
Qlife Holding
Analyst Comment

Interview with CEO Magnus Corfitzen from Ascelia Pharma on latest data on the SPARKLE study.

2023-03-03 by Claus Thestrup
Ascelia Pharma
Analyst Comment

BoMill appoints new Head of Sales

2023-03-01 by Claus Thestrup
BoMill
Analyst Comment

NeoDynamics is investigating options to raise long-term capital to enable commercialization of NeoNavia in the US

2023-03-01 by Claus Thestrup
Neodynamics
Analyst Comment

InDex Pharmaceuticals will attend the ECCO 2023 congress

2023-02-28 by Claus Thestrup
InDex Pharmaceuticals Holding
Analyst Comment

Interview with CEO Ulrich Krasilnikoff and CSO Andreas Kjær on highlights from FY 2022 and update on pipeline

2023-02-28 by Claus Thestrup
Curasight